Related Experiment Video
Updated: Apr 19, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
MicroRNA-302a functions as a putative tumor suppressor in colon cancer by targeting Akt
Shengjie Sun1, Guoqing Zhang1, Zhiyong Wu1
1Department of Oncology, General Hospital of People's Liberation Army, Beijing, 100853, China.
Abstract:
Micro RNAs (miRNAs) are important regulators involved in various physical and pathological processes, including cancer. The miRNA-302 family has been documented as playing a critical role in carcinogenesis. In this study, we investigated the role of miRNA-302a in colon cancer. MiRNA-302a expression was detected in 44 colon cancer tissues and 10 normal colon tissues, and their clinicopathological significance was analyzed. Cell proliferation and cell cycle analysis were performed on colon cancer cells that stably expressed miRNA-302a. The target gene of miRNA-302a and the downstream pathway were further investigated. Compared with normal colon tissues, miRNA-302a expression was downregulated in colon cancer tissues. Overexpression of miRNA-302a induced G1/S cell cycle arrest in colon cancer cells, and suppressed colon cancer cell proliferation both in vitro and in vivo. Furthermore, miRNA-302a inhibited AKT expression by directly binding to its 3' untranslated region, resulting in subsequent alterations of the AKT-GSK3β-cyclin D1 pathway. These results reveal miRNA-302a as a tumor suppressor in colon cancer, suggesting that miRNA-302a may be used as a potential target for therapeutic intervention in colon cancer.
Insights
MicroRNAs (miRNAs), specifically miRNA-302a, are downregulated in colon cancer. Restoring miRNA-302a suppresses tumor growth and proliferation, indicating its potential as a therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Context:
- Micro RNAs (miRNAs) are key regulators in biological processes, including cancer development.
- The miRNA-302 family is implicated in carcinogenesis.
- Colon cancer remains a significant global health challenge.
Purpose:
- To investigate the role and mechanism of miRNA-302a in colon cancer.
- To analyze miRNA-302a expression levels in colon cancer tissues.
- To evaluate the functional impact of miRNA-302a on colon cancer cell behavior.
Summary:
- MiRNA-302a expression is significantly downregulated in colon cancer tissues compared to normal tissues.
- Overexpression of miRNA-302a inhibits colon cancer cell proliferation and induces G1/S cell cycle arrest in vitro and in vivo.
- MiRNA-302a directly targets AKT, modulating the AKT-GSK3β-cyclin D1 pathway.
Impact:
- MiRNA-302a functions as a tumor suppressor in colon cancer.
- These findings highlight miRNA-302a as a potential therapeutic target for colon cancer treatment.
- Understanding miRNA-302a's role provides insights into colon cancer pathogenesis.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation

